FATE - Fate Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$4.00
DETAILS
HIGH:
$4.00
LOW:
$4.00
MEDIAN:
$4.00
CONSENSUS:
$4.00
UPSIDE:
77.78%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Revenue | 6.6 | 13.6 | 63.5 | 96.3 | 55.8 | 31.4 | 10.7 | 4.7 | 4.1 | 4.4 | 2.4 | 0 | 1.0 | 2.7 | 1.2 |
| Cost of Revenue | 12.9 | 0 | 157.2 | 13.8 | 5.8 | 125.6 | 0 | 56.0 | 34.4 | 26.5 | 19.9 | 16.4 | 12.0 | 12.0 | 0 |
| Gross Profit | (6.3) | 13.6 | (93.7) | 82.5 | 50.0 | (94.2) | 10.7 | (51.3) | (30.3) | (22.1) | (17.4) | (16.4) | (11.0) | (9.3) | 1.2 |
| Operating Expenses | |||||||||||||||
| R&D Expenses | 107.8 | 135.0 | 172.6 | 320.5 | 215.5 | 125.6 | 87.8 | 56.0 | 34.4 | 26.5 | 19.9 | 16.4 | 12.0 | 12.0 | 9.9 |
| SG&A Expenses | 46.5 | 74.2 | 96.9 | 84.2 | 57.3 | 33.9 | 23.6 | 15.8 | 11.9 | 9.9 | 10.4 | 8.5 | 6.6 | 4.2 | 4.6 |
| Other Expenses | (12.9) | 14.7 | (172.6) | (13.8) | (5.8) | (125.6) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 141.4 | 223.9 | 96.9 | 390.9 | 267.0 | 33.9 | 111.4 | 71.8 | 46.2 | 36.4 | 30.2 | 24.9 | 18.6 | 16.2 | 14.5 |
| Operating Income | |||||||||||||||
| Operating Income | (147.7) | (210.3) | (190.5) | (308.4) | (217.0) | (128.1) | (100.7) | (67.1) | (42.1) | (32.0) | (27.8) | (24.9) | (17.7) | (13.6) | (13.3) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 1.8 | 1.7 | 1.3 | 1.6 | 2.2 | 0.5 | 0.8 | 0.5 | 0.1 |
| Interest Income | 11.1 | 17.3 | 17.2 | 5.8 | 1.3 | 2.4 | 4.3 | 2.2 | 0.6 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Profitability | |||||||||||||||
| EBITDA | (127.0) | (176.6) | (172.2) | (294.6) | (211.1) | (125.0) | (94.2) | (63.7) | (40.7) | (30.9) | (27.1) | (24.4) | (19.5) | (13.2) | (12.6) |
| EBIT | (136.3) | (195.5) | (190.5) | (308.4) | (217.0) | (128.1) | (96.4) | (64.9) | (41.7) | (31.8) | (27.8) | (25.3) | (20.1) | (13.8) | (13.3) |
| Income Before Tax | (136.3) | (186.3) | (160.9) | (281.7) | (212.2) | (173.4) | (98.1) | (66.6) | (43.0) | (33.5) | (30.0) | (25.9) | (20.9) | (14.2) | (13.4) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.3 | 0 | 0 | 0.1 | 0 | 0 | 0.1 |
| Net Income | (136.3) | (186.3) | (160.9) | (281.7) | (212.2) | (173.4) | (98.1) | (66.6) | (43.0) | (33.5) | (30.0) | (25.9) | (20.9) | (14.2) | (13.4) |
| Per Share Data | |||||||||||||||
| EPS (Basic) | -1.15 | -1.64 | -1.64 | -2.91 | -2.24 | -2.10 | -1.43 | -1.19 | -1.02 | -1.05 | -1.18 | -1.27 | -1.07 | -1.61 | -1.51 |
| EPS (Diluted) | -1.15 | -1.64 | -1.64 | -2.91 | -2.24 | -2.10 | -1.43 | -1.19 | -1.02 | -1.05 | -1.18 | -1.27 | -1.06 | -1.61 | -1.51 |
| Shares Outstanding | 118.8 | 113.7 | 98.4 | 96.8 | 94.7 | 82.4 | 68.2 | 56.2 | 42.0 | 31.8 | 25.5 | 20.5 | 19.4 | 8.9 | 8.9 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 46.6 | 36.1 | 41.9 | 61.3 | 133.6 | 167.3 | 99.8 | 190.5 | 89.0 | 88.6 |
| Short-Term Investments | 157.0 | 243.0 | 273.3 | 374.9 | 482.3 | 315.6 | 121.6 | 10.5 | 12.0 | 3.5 |
| Net Receivables | 0.9 | 3.5 | 1.8 | 38.5 | 8.7 | 5.5 | 0 | 0.5 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 4.1 | 9.3 | 0.9 | 27.4 | 0 | 5.9 | 5.7 | 0 | 1.6 | 1.2 |
| Total Current Assets | 208.7 | 291.9 | 331.5 | 502.1 | 633.4 | 494.3 | 227.1 | 205.2 | 102.6 | 93.3 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 98.5 | 110.9 | 158.5 | 66.1 | 162.2 | 99.4 | 22.8 | 5.1 | 2.5 | 1.6 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 1.5 | 27.7 | 1.0 | 4.9 | 100.7 | 28.7 | 39.4 | 2.2 | 0.1 | 0.1 |
| Other Non-Current Assets | 10.2 | 10.2 | 15.2 | 132.5 | 25.1 | 0.0 | 13.0 | 0.5 | 0.0 | 0.0 |
| Total Non-Current Assets | 110.2 | 148.8 | 174.7 | 203.5 | 288.0 | 128.1 | 75.2 | 7.8 | 2.7 | 1.7 |
| Total Assets | 318.9 | 440.7 | 506.2 | 705.6 | 921.5 | 622.5 | 302.3 | 213.0 | 105.3 | 95.0 |
| Current Liabilities | ||||||||||
| Account Payables | 2.7 | 9.4 | 4.7 | 8.3 | 8.6 | 6.3 | 5.8 | 4.2 | 1.7 | 0.9 |
| Short-Term Debt | 4.6 | 0 | 0 | 0 | 0 | 3.4 | 0 | 2.4 | 0 | 8.2 |
| Deferred Revenue | 0.4 | 0.4 | 0 | 42.2 | 21.5 | 21.1 | 2.8 | 7.6 | 2.1 | 2.1 |
| Other Current Liabilities | 28.5 | 11.6 | 0.7 | 40.0 | 3.2 | 50.0 | 12.2 | 10.1 | 5.5 | 2.5 |
| Total Current Liabilities | 36.1 | 38.5 | 39.1 | 114.1 | 81.3 | 85.6 | 27.8 | 27.3 | 11.0 | 15.2 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 73.3 | 0 | 0 | 0 | 0 | 0 | 0 | 12.4 | 14.8 | 2.5 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 2.4 | 5.6 | 1.3 | 3.9 | 25.0 | 12.5 | 0.7 | 5.4 | 1.5 | 1.4 |
| Total Non-Current Liabilities | 75.7 | 83.4 | 98.7 | 107.6 | 161.3 | 152.4 | 29.7 | 25.3 | 17.1 | 6.7 |
| Total Liabilities | 111.8 | 122.0 | 137.8 | 221.6 | 242.6 | 238.0 | 57.5 | 52.6 | 28.1 | 21.9 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 |
| Retained Earnings | (1,534.3) | (1,398.0) | (1,211.7) | (1,050.8) | (769.1) | (556.9) | (383.5) | (285.4) | (218.8) | (175.8) |
| Accumulated Other Comprehensive Income | 0.1 | 0.3 | 0.0 | (1.9) | (0.8) | 0.1 | 0.0 | (0.0) | (0.0) | (0.0) |
| Total Stockholders' Equity | 207.2 | 318.7 | 368.4 | 483.9 | 678.8 | 384.4 | 244.8 | 160.5 | 77.2 | 73.2 |
| Total Liabilities & Equity | 318.9 | 440.7 | 506.2 | 705.6 | 921.5 | 622.5 | 302.3 | 213.0 | 105.3 | 95.0 |
| Debt Metrics | ||||||||||
| Total Debt | 77.8 | 85.3 | 103.5 | 109.3 | 114.8 | 97.3 | 26.9 | 14.9 | 14.8 | 10.7 |
| Net Debt | 31.2 | 49.2 | 61.7 | 48.0 | (18.8) | (70.0) | (72.9) | (175.6) | (74.1) | (77.9) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (136.3) | (186.3) | (160.9) | (281.7) | (212.2) | (173.4) | (98.1) | (66.6) | (43.0) | (33.5) |
| Depreciation & Amortization | 9.3 | 19.0 | 18.3 | 13.8 | 5.8 | 3.1 | 2.2 | 1.2 | 1.0 | 0.9 |
| Stock-Based Compensation | 24.9 | 41.5 | 43.5 | 78.7 | 54.4 | 30.8 | 17.4 | 6.3 | 3.6 | 3.2 |
| Change in Working Capital | (3.7) | (2.0) | 19.2 | (34.7) | 2.1 | (12.8) | 3.6 | 1.7 | 2.1 | 1.2 |
| Other Non-Cash Items | (0.2) | 4.9 | (52.3) | (24.3) | (13.0) | 113.1 | (7.8) | 19.0 | (0.6) | (1.6) |
| Operating Cash Flow | (106.1) | (122.9) | (132.3) | (248.2) | (162.9) | (39.2) | (83.2) | (38.6) | (36.9) | (29.8) |
| Investing Activities | ||||||||||
| Capital Expenditure | (6.0) | (0.7) | (6.2) | (35.6) | (50.7) | (4.9) | (7.4) | (2.3) | (1.7) | (0.5) |
| Acquisitions | 0.4 | 0 | 0 | 0 | 0 | 0 | 150.1 | 0 | 0 | 0.0 |
| Purchases of Investments | (195.1) | (317.8) | (358.8) | (404.8) | (968.2) | (277.3) | (248.9) | (55.7) | (40.0) | (19.7) |
| Sales/Maturities of Investments | 311.9 | 330.7 | 477.6 | 607.1 | 694.8 | 121.2 | 98.8 | 57.5 | 31.5 | 16 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | (150.1) | 1.8 | (8.5) | 0.0 |
| Investing Cash Flow | 111.2 | 12.2 | 112.7 | 166.8 | (324.0) | (161.1) | (157.5) | (0.5) | (10.2) | (4.1) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | (15) | 0 | 4.1 | (7.7) |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 5.5 | 5.1 | 0 | 0 | 41.4 | 0.5 | 2.5 | 6.2 | 0.3 | 0.2 |
| Financing Cash Flow | 5.5 | 99.9 | 0.1 | 9.2 | 453.1 | 282.8 | 149.9 | 140.8 | 47.4 | 57.7 |
| Cash Position | ||||||||||
| Net Change in Cash | 10.6 | (5.8) | (19.5) | (72.2) | (33.8) | 67.5 | (90.7) | 101.7 | 0.3 | 23.8 |
| Cash at Beginning | 46.3 | 41.9 | 61.3 | 133.6 | 182.6 | 99.8 | 190.7 | 89.1 | 88.7 | 64.8 |
| Cash at End | 56.9 | 36.1 | 41.9 | 61.3 | 148.8 | 167.3 | 100.0 | 190.7 | 89.1 | 88.6 |
| Free Cash Flow | (112.0) | (123.6) | (138.4) | (283.8) | (213.6) | (44.2) | (90.6) | (41.0) | (38.6) | (30.3) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||
| Revenue | 6.6 | 13.6 | 63.5 | 96.3 | 55.8 | 31.4 | 10.7 | 4.7 | 4.1 | 4.4 | 2.4 | 0 | 1.0 | 2.7 | 1.2 |
| Gross Profit | (6.3) | 13.6 | (93.7) | 82.5 | 50.0 | (94.2) | 10.7 | (51.3) | (30.3) | (22.1) | (17.4) | (16.4) | (11.0) | (9.3) | 1.2 |
| Operating Income | (147.7) | (210.3) | (190.5) | (308.4) | (217.0) | (128.1) | (100.7) | (67.1) | (42.1) | (32.0) | (27.8) | (24.9) | (17.7) | (13.6) | (13.3) |
| Net Income | (136.3) | (186.3) | (160.9) | (281.7) | (212.2) | (173.4) | (98.1) | (66.6) | (43.0) | (33.5) | (30.0) | (25.9) | (20.9) | (14.2) | (13.4) |
| EPS (Diluted) | -1.15 | -1.64 | -1.64 | -2.91 | -2.24 | -2.10 | -1.43 | -1.19 | -1.02 | -1.05 | -1.18 | -1.27 | -1.06 | -1.61 | -1.51 |
| Balance Sheet | |||||||||||||||
| Cash & Equivalents | 46.6 | 36.1 | 41.9 | 61.3 | 133.6 | 167.3 | 99.8 | 190.5 | 89.0 | 88.6 | |||||
| Total Assets | 318.9 | 440.7 | 506.2 | 705.6 | 921.5 | 622.5 | 302.3 | 213.0 | 105.3 | 95.0 | |||||
| Total Debt | 77.8 | 85.3 | 103.5 | 109.3 | 114.8 | 97.3 | 26.9 | 14.9 | 14.8 | 10.7 | |||||
| Stockholders' Equity | 207.2 | 318.7 | 368.4 | 483.9 | 678.8 | 384.4 | 244.8 | 160.5 | 77.2 | 73.2 | |||||
| Cash Flow | |||||||||||||||
| Operating Cash Flow | (106.1) | (122.9) | (132.3) | (248.2) | (162.9) | (39.2) | (83.2) | (38.6) | (36.9) | (29.8) | |||||
| Capital Expenditure | (6.0) | (0.7) | (6.2) | (35.6) | (50.7) | (4.9) | (7.4) | (2.3) | (1.7) | (0.5) | |||||
| Free Cash Flow | (112.0) | (123.6) | (138.4) | (283.8) | (213.6) | (44.2) | (90.6) | (41.0) | (38.6) | (30.3) | |||||